Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Participants in Annual Workplace Health Evaluation Program had Lower Risk for Developing Diabetes

American Diabetes Association 83rd Scientific Sessions

ADA 2023

San Diego, CA, June 23-26, 2023

Poster presentation: Participants in Annual Workplace Health Evaluation Program had Lower Risk for Developing Diabetes

Authors:  Tong CH, Jalandoni-Bustamante M, Fragala MS, Birse CE

Specialty: Endocrinology, Cardiology, Cardiovascular disease

Related content

Audio Podcast
Commitment to Employee Health: A Blueprint for Wellness
Publication
Early insights from a pharmacogenomic-enriched comprehensive medication management program implementation in an adult employee population
Publication
Contributions of Glucose and Hemoglobin A1c Measurements in Diabetes Screening
Publication
Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for Employers
Conference Presentation
Risk of Type 2 Diabetes Is Reduced in the Second Year of a Digital Diabetes Prevention Program in a Workplace Setting

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.